NX DEVELOPMENT CORP.

nx-development-corp-logo

Upon conducting research with leaders in the field, it is clear that an ideal solution for neurosurgeons approaching removal of Glioblastoma is a procedure which: increases the precision and extent of tumor resection, has a manageable capital equipment cost for the hospital and has appropriate cost-benefit characteristics to the payers and does not introduce new medical risk factors - the use of Gliolanโ„ข in conjunction with existing and growing installed base of fluorescence add-on kits manufactured by the two leading surgical microscope manufacturers provides just such a solution.

#People #Financial #Website #More

NX DEVELOPMENT CORP.

Industry:
Biotechnology Health Care Health Diagnostics Therapeutics

Founded:
2010-01-01

Address:
Louisville, Kentucky, United States

Country:
United States

Website Url:
http://www.nxdevcorp.com

Total Employee:
11+

Status:
Active

Contact:
(305)929-3125

Email Addresses:
[email protected]

Total Funding:
2.51 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Universal Analytics Amazon IPv6 Google Maps Cloudflare Cloudflare Network Error Logging


Current Employees Featured

alan-ezrin_image

Alan Ezrin
Alan Ezrin Chairman & CEO @ NX Development Corp.
Chairman & CEO
2015-01-01

Founder


alan-ezrin_image

Alan Ezrin

Investors List

keyhorse_image

Keyhorse Capital (KSTC)

Keyhorse Capital (KSTC) investment in Seed Round - NX Development Corp.

Official Site Inspections

http://www.nxdevcorp.com

  • Host name: 141.0.153.160.host.secureserver.net
  • IP address: 160.153.0.141
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "NX Development Corp."

Brain Cancer Solutions | NX Development Corp

At NX Development Corp, we are changing the way brain cancer is treated. Our product, Gleolan is used to help neurosurgeons remove malignant tissue during surgery in patients with high โ€ฆSee details»

NX Development Corp. | LinkedIn

NX Development Corp. | 1,434 followers on LinkedIn. Visualizing cancer in a different light.See details»

Contact | Pharmaceutical Development | NX Development Corp

At NX Development Corp, we value your feedback and inquiries about our innovative solutions in the field of neurosurgery, brain cancer, and pharmaceutical development. You may also reach โ€ฆSee details»

NX Development Corp. - Crunchbase Company Profile โ€ฆ

NX Development is a life sciences company that develops real-time intra-operative imaging agents. View contacts for NX Development Corp. to access new leads and connect with decision-makers.See details»

Careers | Equal Opportunity Employer | NX Development Corp

NX Development Corp is advancing the field of neurosurgery and fluorescent visualization, and we are always on the lookout for talented individuals who share our passion and commitment โ€ฆSee details»

NX Development Corp. is Granted Orphan-Drug Designation โ€ฆ

LEXINGTON, KY / ACCESSWIRE / March 5, 2024 / NX Development Corp. (NXDC) has achieved another milestone as we proudly announce the recent granting of orphan-drug status โ€ฆSee details»

NX Development Corp. Enrolls First Patient in OVA-302 Study

Jun 21, 2024ย ยท About NX Development Corp: NX Development Corp., a wholly owned subsidiary of photonamic GmbH & Co. KG, a member of the SBI Holdings Inc. Group (Tokyo, Japan), is โ€ฆSee details»

NX Development - Overview, News & Similar companies - ZoomInfo

Mar 1, 2022ย ยท NX Development contact info: Phone number: (833) 453-6526 Website: www.nxdevcorp.com What does NX Development do? NX Development Corp. (NXDC) is a life โ€ฆSee details»

NX Development Corp. (NXDC) Receives FDA Orphan-Drug โ€ฆ

Lexington, KY, Jan. 12, 2021 (GLOBE NEWSWIRE) -- NX Development Corp. (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced FDA โ€ฆSee details»

Company News - Latest Announcements - NX DevCorp - NX โ€ฆ

Mar 5, 2024ย ยท Stay updated with NX DevCorp's latest news and announcements. Read our press releases and updates. Visit our news section.See details»

NX Development Corp. (NXDC) Names Salvatore โ€ฆ

Mar 2, 2022ย ยท NX Development Corp. is a research and development company focused on new 5-ALA indications via clinical trial programs in multiple tumor types. The company was acquired in 2018 by photonamic (PHN)...See details»

NX Development Corp. is Granted Orphan-Drug Designation

LEXINGTON, Ky., March 5, 2024 (Newswire.com) - NX Development Corp. (NXDC) has achieved another milestone as we proudly announce the recent granting of orphan-drug status by the โ€ฆSee details»

NX Development Corp. (NXDC) Receives FDA Orphan-Drug

Lexington, KY, Jan. 12, 2021 (GLOBE NEWSWIRE) -- NX Development Corp. (NXDC), a life sciences company wholly owned by photonamic GmbH & Co. KG., today announced FDA โ€ฆSee details»

NX Development Corp. is Granted Orphan-Drug Designation โ€ฆ

LEXINGTON, Ky., March 5, 2024 (Newswire.com) - NX Development Corp. (NXDC) has achieved another milestone as we proudly announce the recent granting of orphan-drug status by the โ€ฆSee details»

T.J. Stalvey Joins NX Development Corp. (NXDC) as Vice

Lexington, KY, April 15, 2021 (GLOBE NEWSWIRE) -- NX Development Corp. (NXDC), a life-sciences company wholly owned by photonamic GmbH & Co. KG., today announced that โ€ฆSee details»

Current Approvals - View Latest Updates - NX DevCorp

Check NX DevCorp's current approvals for our latest project updates. Stay informed about our progress. Contact us for more details.See details»

NX Development Corp. (NXDC) Launches FDA-Approved Gleolanโ„ข

Oct 3, 2018ย ยท NX Development Corp. (NXDC) is a life sciences company based in Lexington, KY dedicated to the development of ALA HCl for tumor visualization. NXDC is a wholly-owned โ€ฆSee details»

NX Development Corp. | Lexington KY - Facebook

NX Development Corp., Lexington, Kentucky. 1,535 likes ยท 3 talking about this. Visualizing cancer in a different light. Disclaimer: https://nxdevcorp.com/social-media-disclaimerSee details»

Press Release - First Patient OVA-302 June 2024 - NxDev

Jun 21, 2024ย ยท NX Development Corp., a wholly owned subsidiary of photonamic GmbH & Co. KG, a member of the SBI Holdings Inc. Group (Tokyo, Japan), is dedicated to revolutionizing โ€ฆSee details»

Pipeline | Our Plans at NX Development Corp

Have an idea for doing a study with Gleolan? Get more information on our plans and developments at NX Development Corp by visiting our company website today.See details»

linkstock.net © 2022. All rights reserved